Summary
A simple and sensitive assay for phenylephrine in plasma using HPLC with electrochemical detection is presented. Infusion of phenylephrine hydrochloride 0.5, 1.0, 2.0, and 4.0µg × kg−1 × min−1 for 6 min at each dose level to 9 healthy subjects resulted in mean venous plasma concentrations of phenylephrine of 20, 56, 118 and 308 nM, respectively. The systolic and diastolic blood pressures were increased and the heart rate and venous plasma noradrenaline levels fell with increasing phenylephrine concentrations.
There was a more than two-fold interindividual variation in the plasma concentration during infusion of the standardized doses of phenylephrine, with overlap of the concentrations achieved at the different dose levels. Estimates of the sensitivity to phenylephrine showed discrepancies within individuals when expressed as the concentration (PC20) or dose (PD20) required to increase systolic blood pressure by 20 mm Hg. Thus, evaluation of concentration-response curves should be more reliable than of dose-response curves when assessing phenylephrine sensitivity during i.v. infusions.
Similar content being viewed by others
References
Elliot HL, Sumner DJ, McLean K, Reid JL (1982) Effect of age on the responsiveness of vascularα-adrenoceptors in man. J Cardiovasc Pharmacol 4: 388–392
Kotchen TA, Guthrie GP, McKean H, Kotchen JM (1982) Adrenergic responsiveness in prehypertensive subjects. Circulation 65: 285–290
Dombrowski LJ, Comi PM, Pratt EL (1973) GLC Determinations of Phenylephrine hydrochloride in human plasma. J Pharm Sci 62: 1761–1763
Watson JR, Lawrence RC (1977) Selective GLC determination of epinephrine, isoproterenol and phenylephrine in pharmaceutical dosage forms. J Pharm Sci 66: 560–564
Schieffer GW, Hughes DE (1983) Simultaneous stability-indicating determination of phenylephrine hydrochloride, phenylpropanolamine hydrochloride and guaifenicin in dosage forms by reversed-phase paired-ion high-performance liquid chromatography. Am Pharm Sci 72: 55–59
Hjemdahl P, Daleskog M, Kahan T (1979) Determinations of plasma catecholamines by high-performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 25: 131–138
Hengstmann JH, Goronzy J (1982) Pharmakokinetics of3H-phenylephrine in man. Eur J Clin Pharmacol 21: 335–341
Koch-Weser J (1981) Therapeutic drug monitoring. A. Richens, V. Marks (eds). Churchill Livingstone, Edinburgh, pp 1–22
Hjemdahl P, Åkerstedt T, Pollare T, Gillberg M (1983) Influence of β-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand 515 [Suppl]: 45–53
Richards DA, Prichard BNC (1978) Concurrent antagonism of isoproterenol and norepinephrine after labetalol. Clin Pharmacol Ther 23: 253–258
Bahr C von, Lindström B, Seideman P (1982)α-Receptor function changes after the first dose of prazosin. Clin Pharmacol Ther 32: 41–47
Kirchheim H (1976) Systemic arterial baroreceptor reflexes. Physiol Rev 56: 100–176
Grossman SH, Davis D, Gunnels JC, Shand DG (1982) Plasma norepinephrine in the evaluation of baroreceptor function in humans. Hypertension 4: 566–571
Hjemdahl P (1984) Catecholamine measurements by high-performance liquid chromatography. Am J Physiol 247: E13-E20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martinsson, A., Bevegård, S. & Hjemdahl, P. Analysis of phenylephrine in plasma: Initial data about the concentration-effect relationship. Eur J Clin Pharmacol 30, 427–431 (1986). https://doi.org/10.1007/BF00607955
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607955